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In this account, I will trace the development of liver replacement (orthotopic liver 
transplantation), tabulate the clinical results obtained so far, and describe the factors 
leading to success or failure. 
Experimental background 
The technique of orthotopic liver transplantation in dogs was developed independently 
in two widely separated laboratories, one in Boston (1) and the other in Chicago (2,3). 
These efforts in nonimmunosuppressed animals delineated the typical pattern of acute 
rejection (1,3). After operation, the animals often seemed quite normal for several days, 
even resuming a diet. However, within four or five days, jaundice appeared along with 
rises in serum transminases denoting massive hepatocyte necrosis. The light and electron 
microscopic changes in rejecting livers have been well described (1, 3-5) and consist 
principally of mononuclear invasion of and necrosis in the hepatic homograft. 
Chronic survival in canine liver recipients was first achieved in our laboratory, almost 
a decade and a half ago (6), using azathioprine therapy as the sole immunosuppression. 
Nineteen animals from that study survived for at least three postoperative months (5), 
five lived for more than a year, and one dog lived for almost twelve years (Figure 1) 
before dying of complications of old age plus partial biliary tract obstruction. This 
animal was given azathioprine only for the nrst four postoperative mo~ths. Seemingly, 
a change of such m~nitudebad occurred il1W: host-graft relationship. that a fullllf~, .. 
time survival no longer' dePended' oo.inimunosuppressiori~ The samepliehoinenon' was "~~-­
noted in nine other animals. . 
The only other agent which has permitted chronic survival in dog liver recipients has 
been heterologous antilymphocyte serum (ALS) or its globulin derivative which is 
called ALG (7). In pigs, chronic survival has been possible without immunosuppression 
(5,8-10). 
Clinical immunosuppression 
In spite of these achievements in individual experiments, the consistency with which 
really long-term survival was obtained was poor. There were at least two obvious 
reasons. First, complete control of rejection was usually not achieved. Second, it was 
difficult to prevent or to treat infectious disease complications or to provide~er .e.f'~ 
niceties of special care in a standard kennel or piggery environment. It is.probab that· ilJ 
the animal data would have indefinitely discouraged a clinical trial had it not been for ~ 
the example of renal homotransplantation. With the latter procedure, the surprising 
frequency with which long survival was eventually achieved in man could hardly have 
been predicted from the 'prior laboratory results which, if anything, were less favorable 
than those after experimental liver transplantation. In addition, the human experience 
with the kidney did more than serve as an incentive. It also provided the conditions in 
which complex and effective immunosuppressive regimens could be evolved in man and 
applied, in turn, to the transplantation of other organs. 
, . 
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For the treatment of our human liver recipients of both orthotopic and auxiliary homo-
grafts two .treatment protocols were applied after extensive personal experience had 
already been acquired in clinical renal transplantation. The first program consisted of 
double drug therapy with azathioprine and prednisone to which less important or even 
questionable ancillary measures were sometimes added; in nine trials there were no 
survivals of more than 34 days. Subsequent liver recipients were given triple agent 
therapy with azathioprine (which may be replaced with cyclophosphamide), withpred-
nisone and with heterologous antilymphocyte globulin (ALG). The purified immuno-
globulin (ALG) was obtained from the serum of horses or rabbits immunized against 
human lymphocytes. Thus ALG administration was an attempt at lymphoid depletion. 
The only really dose maneuverable component of the triple drug regimen was the pred-
nisone which was raised or lowered according to the presence or absence of rejection. 
The way in which these agents were (and are) used is shown in Figures 2 and 3. 
Indications for transplantation 
Of all the indications for liver replacement, biliary atresia is the most clear. Into these 
children is made a great social and medical input, from which no conceivable long-
term benefit can be expected, since they inevitably die and at a fairly predictable time 
if a porticoenterostomy is not successful. Thus, one can intervene with a clear con-
science before the patients reach a 'moribund state. In our series, biliary atresia has been 
the single most common reason for liver transplantation (see Table 3). 
When Kasai's porticoenterostomy began to be used extensively for biliary atresia, we 
feared at first that the extensive dissection required for this operation would jeopardize 
subsequent transplantation. However, this has not been a problem. There has even been 
the advantage that the Roux-Y jejunal limb constructed for the Kasai procedure can be 
reused to drain the homograft biliary trac~. 
Chronic aggressive hepatitis has been another common indication for liver transplanta-
tion both in adults and children. The majority of these patients have been virus free 
insofar as could be determined, but some have had preexisting Australia antigenemia. 
The first long survivor who carried the HBsAg marker became Australian antigen ne-
gative as judged by agarose gel and complement fixation methods and remained that 
way for about two months (Figure 2). Although later testing with the p:1ore sensit~ve 
radioimmunoassay showed that trace quantities of HBsAg were always present, the 
nearly complete clearing during this time indicated that the major focus of the virus had 
been in her native liver. About two months postoperatively, at about the time when 
she would have expected to develop serum hepatitis had she been infected de novo at 
the time of transplantation, she head increases in bilirubin, rises in transaminases, joint 
pains, and a return positive HBsAg with all the screening tests (Figure 2). Immuno-
suppression was not increased. She recovered spontaneously, but remained HBsAg po-
sitive and slowly recapitulated a variation of her orginal disease, dying after almost 
two years of nocardial brain abscesses combined with hepatic failure. In spite of this 
experience, the presence of a virus in these patients does not contraindicate liver trans-
plantation. Now such patients can be treated with specific hyperimmune globulin start-
ing on the day of operation when the titer of the virus is made low by removal of the 
native liver. We have thereby cleared the virus for many postoperative months, and 
the same thing has been accomplished by Caine et al (11). 
Alcoholic cirrhosis is one of the most important potential reasons to consider liver 
transplantation, but the time of operation may be difficult to decide, particularly if 
abstinence from alcohol is not achieved in advance. Furthermore, the damage done to 
the central nervous system by hepatic failure, and the consequences to other organ 
systems by self abuse as well as for metabolic reasons constitute a severe handicap. 
Failure of the extrahepatic complications to reverse or come under control have caused 
the death 9f a number of these recipients. Only recently have our results with Laennec's 
cirrhosis provided any encouragement. 
An exceptionally interesting group of patients have had liver replacement for inborn 
errors of metabolism which are known or presumed to be liver based. All hepatic based 
inborn errors of metabolism are curable by successful hepatic transplantation since the 
synthetic products and enzyme specificity of the new liver remains that of the donor (5). 
Even some metabolic disorders in which the exact enzyme defect is not known have 
, ' 
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been cured by liver transplantation. An example of the latter is Wilson's disease, 
victims of which accumulate copper in the liver, brain and elsewhere causing the lesions 
of Wilson's disease including the typical Kayser-Fleisher rings in the eyes. Wilson's 
disease is an inherited disorder in which most patient have a reduced or abent serum 
ceruloplasm. After hepatic transplantation for Wilson's disease, the ceruloplasm in-
creased in one of our patients from essentially zero to normal levels, and it stayed that 
way for more than seven years post-transplantation (Figure 3). After operation de-
coppering was evident in a cupruresis for many months (Figure 3). This patient's most 
severe complication of Wilson's disease was progressive neurologic disability. The n~r­
vous system abnormalities reversed over several years and between two and three years 
postoperatively the Kayser-Fleisher rings disappeared. . 
Other examples of inborn errors that we have treated include alpha-1-antitrypsin de-
ficiency, congenital tyrosinemia, and Type IV glycogen storage disease. There are many 
possibilities for further research with other inborn errors. 
Initially, we thought that the presence of primary liver tumors that could not be re-
sected with conventional techniques would be an ideal reason fororthotopiclivertrans-
plantation. This proved to be a vain hope for the most part since recurrence of tumor 
has been seen in more than 90 % of such trials with hepatomas, small duct cell carci-
nomas (Klatskin tumors), and other less common malignancies including hemangio-
endothelial sarcoma (5, 12). With hepatomas, serial alphafetoprotein determinations 
have helped follow the evolution of metastases. With all kinds of tumors, a striking 
tendency has been seen for the recurrences to "home" back to the graft itself. 
Tumor recurrence may not be an inevitable complication. An exception in our series is 
a little girl who had a hepatoma as an incidental finding in a liver that was removed 
because of biliary atresia. Preoperatively, she had a positive alphafetoprotein examina-
tion. The abnormal protein disappeared after the surprisingly long interval of four 
months. She has remained alphafetoprotein negative and tumor free since that time. 
She is now 81/2 years posttransplantation and the longest surviving liver recipient in 
the world. 
In addition, palliation has been possible in some other cases although eventually there 
was tumor recurrence. We have had two men with the small duct cell carcinomas 
(Klatskin tumors) at the confluence of the right and left hepatic ducts. One lived for 
two years before dying of metastases. The other is surviving but with recurrent tumor 
and will be four years postoperative in September if he lives that long. We have a 
female patient who is coming up to two years after surviving liver replacement for a 
sclerosing cholangiocarcinoma. She has small quiescent pulmonary metastases which 
have been present since the time of transplantation. Perhaps the door is not entirely 
closed on hepatic malignancy as an indication for liver transplantation although for 
the reasons I have stated, the yield in terms of cure will be small . 
... 
__ -:"_T~o...;s~u.;:mm.:.:.:;:arize indications in more general terms, we think: 1) Ideal recipients should 
· A lf$" be less tha";i~years old. Those who are older cannot stand the rigorous immunosup-
pression which must be imposed postoperatively. 2) The patient should have a hopeless 
prognosis, a point to which I will return in a moment. 3) They sh~uld not have cancer. 
4) They should not have an infection. As I have already implied, we have violated each 
of these guidelines from time to time. If two adverse conditions are present, the outlook 
is virtually hopeless. 
Now, I would like to focus for the moment on the question of what constitutes a hope-
less prognosis. We have treated patients with acute liver disease caused by halothane, 
isoniazid, and viruses who seemed to have no hope for survival. Yet, they have re-
covered fully with supportive care including ventilation, exchange transfusion, and 
renal dialysis. Because of such admittedly uncommon experiences, we are reluctant to 
proceed with liver replacement for acute disease. Perhaps there could be a role here for 
auxiliary transplantation whereby a second ectopically placed liver could be used tem-
porarily to tide the patient over the crisis and to allow recovery of the native liver. 
In patients with chronic liver disease, it is really important to have a longitudinal view 
of their course before accepting them for tr<:insplantati6n. Such a view has been made 
possible by collaboration with profound students of liver disease. We have developed 
a network of communication with many of th~hepatology centers in the United 
States. When referrals come from such sources, l.J>have confidence that the time is ripe 
. . 'f"~~ 
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for treatment, even if our own opportunity for observation is limited. When a patient 
becomes invalided so that he or she cannot function in society and cannot work, we 
believe further delay is inadvisable. The past practice of taking moribund patients to 
the operating room for such an extensive procedure will not permit an improvement 
in results. 
A notation is in order here about the inconsequential role of tissue typing in liver 
transplantation. No correlation has been observed between HL-A typing and the 
clinical outcome (12). Surprisingly, even a positiye cytotoxic crossmatch showing pre-
formed anti donor antibodies in the recipient serum has not led to hyperacute rejection 
(12) as would be expected after renal transplantation. 
Technique of liver replacement 
The essential first step in liver transplantation is to obtain a good cadaveric organ from 
a brain dead donor who still has an effective circulation. The organ can be excised in 
an orderly way and chilled by infusing cold fluid such as lactated Ringers solution with 
or without low molecular weight dextran through the portal·vein. The cooled liver 
will tolerate several hours of ischemia. 
There has been an important practical breakthrough in the last two or three years in 
asmuch as cadaveric livers have been infused with special solutions which mimic 
plasma (13) or alternatively which have an electrolyte composition similar to that.in 
cells (14). The latter fluid which is known as Collins solution has permitted the cold 
preservation of canine livers safely in our laboratories for 12 to 18 hours. As a clinical 
extension, it has been possible for us to harvest human livers in California, Minnesota 
and other distant places, to carry the liver to Denver on commercial airplanes, and to 
successfully transplant the organs in Colorado. Thus, the possibility of a national liver 
procurement network has emerged. 
In the meanwhile, the recipient operation is usually done through a basic subcostal 
incision, very often with an extension into the right chest through the seventh inter-
costal space or with a superior midline extension including excision of the zyphoid 
process (Figure 4). There usually.are formidable technical problems because of the ex-
tensive venous collaterals which can render hemostasis almost impossible. The problem 
is compounded by the fact that clotting factors are never .normal. In our early experi-
ence, most adult patients with cirrhosis lost 30 to 50 units of blood and the operations 
were almost always eight to twelve hours or longer. Some technical modifications have 
improved the situation. Of these, the most important is removal of the liver by trans-
ecting the infrahepatic vena cava and the portal triad structures entering it, by remov-
ing it from below while pulling on the hilar structures and vena cava, and by ligating 
all of the tissues that are cut behind. When the upper end of the liver is reached, a 
clamp can be placed across the suprahepatic vena cava, and a cuff of the vena cava 
developed for suture by dissecting off the cirrhotic liver (Figure 5). 
In concept, liver transplantation is a simple operation which consists of connecting the 
blood vessels, coming into and going out of the liver in as normal a way as possible and 
then reconstitution of biliary drainage (Figure 6). There are two vena caval anastomo-
ses, one below and one above the liver. For the last two years, we have continuously 
infused the homografts through the portal vein during the time of the vena caval an-
astomoses, allowing air bubbles trapped in the homograft to come out as the suture 
lines were completed (Figure 7). Omission of this precaution in early cases resulted in 
air embolus, particularly in adult recipients (15). The air floated to the right heart and 
because of the extensive venous anastomoses from right to left in patients with liver 
disease, these emboli passed straight to the left heart and up to the brain causing grave 
neurologic damage. 
For biliary reconstruction in most of our early cases, cholecystoduodenostomy (Fig-
ure 6 A) was used because it was the simplest and fastest way to complete a long and 
tiring operation. The patients had an extraordinary incidence of symptomatic or asym-
ptomatic bacteremia (5). It seemed as if the liver itself was the focus of and the entry 
for bacteria: that passed into the general circulation and then caused infections else-
where. Ultimately, it became obvious that the contamination with gastrointestinal con-
tents was causing cholangitis. 
· . 
Clinical 
results 
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Consequently, we now believe that the ideal way of reconstructing the biliary tract is 
simple end-to-end common duct anastomosis (Figure 6 D). Of course in many patients 
(children with biliary atresia for example) this option is not available. Then, we per-
form cholecystojejunostomy (Figure6B) or choledochojejunostomy (Figure6C) anasto-
mosing gall bladder or the common duct to a Roux limb of jejunum. For nonsurgeons 
it is worth pointing out that the Roux principle defunctionalizes a loop of the intestine, 
theoretically allowing the gastrointestinal stream to pass distally to the liver without 
seriously contaminating it. 
Caine and his associates (11) at Cambridge have described an alterootive and some-
what more complicated technique in which the common duct is anastomosed to the 
gallbladder, and the r~s t'ng cloaca connected to the distal common duct. We have 
not had experience wi t' method. 
,S 
Postoperative complications and causes of failure 
Because of the high mortality after liver transplantation, this procedure has not had 
wide clinical application. In an effort to improve the situation, I reviewed the first 
93 consecutive Colorado cases during a sabbatical leave in London in the summer of 
1975. The survey was done in collaboration with Professor K. A. Porter who is a world 
authority on transplantation pathology. We tried in each case to determine the reasons 
for success or failure. The details of this work have been published (12). The central 
findings of that study changed our attitudes about management for all subsequent cases, 
and led to a number of improvements. 
One expected cause of failure was uncontrolled acute rejection. However, it was sur-
prising how relatively infrequently (about 10%) this was the primary reason for 
death. Similarly, chronic rejection, with its typical occlusive vascular lesions and par-
enchymal fibrosis only accounted for a few failures. 
What were the main reasons for the exorbitant mortality up to that time? The majority 
of deaths were found to result from technical or mechanical roblems. These included 
thrombosis of the hepatic artery or portal vein, the use ot raftl 
the development of cerebral air embolus as discussed earlier, a 
tion just fout examples. . 
amaged by ischemia, 
hemorrhage to men-
,,.al'''''' 
However, by far the greatest single cause of technically based mortality was failure of 
the biliary tract reconstruction. In the 93 consecutive cases analyzed in London, almost 
35 % of the patients had either obstruction of or fistula formation from their biliary 
tracts (16). Many of these patients were not treated with re-operation, and the com-
plication was discovered at autopsy. One excuse was that the reconstructions usually 
had been with cholecysto- or choledochoenterostomy. It was not possibly to make the 
diagnosis by. means which are now standard such as percutaneous transhepatic chol-
anigaography, using the so-called skinny (Chiba) needle. It was obvious that patients 
who became jaundiced in the postoperative period were not necessarily having re-
jection, but that there was a good possibility of obstruction. 
Using cholangiography frequently, the kinds of obstructive lesions seen in Figure 8 
were discovered with increasing frequency and ducts were reconstructed secondarily. 
Re-operation and secondary repair of these dilated duct systems was shown to be safe (16). 
I will conclude with some statistics and follow-ups which were brought up to date as 
of a few days ago. The material can be split into two phases. 
To June, 1976 
The first phase was prior to the clinical-pathologic correlations which I mentioned 
that were started in the summer of 1975 and were completed in early 1976. There were 
111 consecutive patients who were treated between 1963 and June, 1976. Only 31 
(28 %) lived for as long as one year (Table 1). Of the 31 patients that lived for a year, 
15 are still surviving after 21/a to 81/2 years. 
Amongst the 111 orginal patients, there were 50 adults (Table 2) including 13 with 
malignancies. Several of these 13 died of recurrent malignancy as described earlier be-
fore or after one year. Chronic aggressive hepatitis and alcoholic cirrhosis were the 
Summary 
Zusammen-
fassung 
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other common diseases treated. With all of the major diagnostic categories, extended 
survival was uncommon. There were only ten (20 0/&) of the 50 adult patients who lived 
for as long as a year, and five are still surviving with follow-ups as short as 28 months 
and as long as about four years. The woman with the Budd-Chiari syndrome (Table 2) 
has had a baby. The patients who died late had survival of 131/2 to25 months (Table 2). 
In the first 111 patients there were 61 who were 18 years or younger. In this pediatric 
subdivision there were 42 examples of biliary atresia with a one year survival of' only 
12 (29 %) (Table 3). In the assortment of other diagnoses were included the inborn 
errors of metabolism, hepatomas, and chronic aggressive hepatitis. Twenty-one (34 0/0) 
of the total pediatric series of 61 lived for a year. Ten are still alive with follow-up of 
31/2 to 81/3 years (Table 4). The 12 late deaths were after one to six years. The most 
remote death was a particularly tragic one caused by a biliary duct complication six 
years following liver replacement for Wilson's disease. Thus, the overall survival in the 
pediatric series was better than with the adults but still poor. 
After June, 1976 
Improvements in technical and diagnostic care were instituted after the case reviews 
which took place in 1975 and early 1976. These included the use of microvascular 
techniques for vascular anastomoses, cholangiography, and liberal use of liver biopsies 
after operation. Since then and with a cut off of December, 1977, we accumulated 
30 more cases (Table 5). The survival in the latest group is now 500f0. Fourteen of the 
15 survivors are more than six months and nine are more than a year. All of these pa-
tients are out of the hospital and from past experience, it seems clear to us that the one 
year mortality overall with liver transplantation is now in the order of 50 0/0*, 
A breakdown of the recipients in the adult and pediatric subgroups is given in Table 6. 
The survival in both categories is about double that in the original series. Perhaps a 
new era in liver transplantation is at hand. 
·f In the month since the lecture, no further deaths have occurred. 
The development of liver transplantation has been difficult. However, substantial ad-
vances have been made mostly because of better surgical techniques and because of 
better postoperative management. It has been necessary for surgeons to be more in-
quisitive about the reasons for post-transplantation liver dysfunction rather than to 
ascribe hepatic perturbations to rejection. With these nonspecific improvements, there 
has been movement of liver transplantation into the area of actual service. Before the 
next great step will be made, there must be an improvement in immunosuppression. 
The nature of such improvement is not yet clear. 
~weAM 0AMfJ t (}(AIA~fhv 
Die Entwicklung der Lebertransplantation war schwierig, dennom wurden wesentliche 
Fortschritte durch bessere chirurgische Technik und besseres postoperatives Management 
erzielt. Es war flir Chirurgen notwendig gewesen, intensiver nach den Ursachen der 
Leberdysfunktion nach der Lebertransplantation zu forschen, als die Leberstorungen 
einer AbstoBungsreaktion zuzuschreiben. Mit unspezifischen Verbesserungen bewegt sich 
die Transplantation auf das Gebiet einer wirksamen Dienstleistung. Bevor der nachste 
Schritt get an wird, muB eine Verbesserung der Immunsuppression erfolgen. Die Art 
und Weise dieser Verbesserung ist nicht klar. 
, . 
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Lived> 1 year 
Alive now 15 (after 21/s-81/a years) 
Table 2: 50 adult patients 
March, 1963, through July, 1976 
(Follow-up to May 1, 1978) 
Diagnosis Number Survival 
of examples 1 year Alive now .... 
Malignant tumor" 13 2 (15 0/0) 1 (44 months) 
Chronic aggressive hepatitis 17 5 (30 0/0) 1 (32 months) 
Alcoholic cirrhosis 11 1 (9 0/0) 1 (49 months) 
Primary biliary cirrhosis 4 0 (0 0/0) 0 
Secondary biliary cirrhosis 1 q (0 0/ 0) 0 
Sclerosing cholangitis 
with ulcerative colitis 1 0 (0,1)10) 0 
Massive hepatic necrosis 
due to hepatitis B virus 1 0 (0 %) 0 
Budd-Chiari syndrome 1 1 (100 0/0) 1 (43 months) 
Congenital biliary hypoplasia 1 1 (100 %) 1 (28 months) 
* 7 hepatomas, 4 duct cell carcinomas, 1 cholangiocarcinoma, and 1 hemangioendothelial sar-
coma. The patient who is still alive had a small obstructing duct cell carcinoma. 
** The 5 deaths after 1 year occurred after 131/2, 151/e, 19, 201/e, and 25 months. 
" 
Gastro 12 
Table 3: 61 pediatric patients 
March, 1963, through Juli, 1976 
(Follow-up to May, 1, 1978) 
Diagnosis 
Congenital biliary atresia 
Chronic aggressive hepatitis 
Hepatoma 
Wilson's disease 
Congenital biliary cirrhosis 
Alphat-antitriypsin-deficiency 
Tyrosinemia 
Giant cell hepatitis 
Total 
Table 4: 61 pediatric patients 
March, 1963, through July, 1976 
(Follow-up to May 1, 1978) 
Diagnosis 
Congenital biliary atresia 
Chronic aggressive hepatitis 
Hepatoma 
Wilson's disease 
Congenital biliary cirrhosis 
Alphat-antitrypsin deficiency 
Total 
Spalte 23 
Number 
of examples 
42 
10 
3 
2 
1 
1 
1 
1 
61 
Alive now 
6/42 
2/10 
01 3 
1/ 2 
1/1 
0/ 1 
10 161 
Survival 
1 year 
12 (29 0/0) 
3 (30 Ofo) 
2 (67%) 
2 (100 Ufo) 
1 (100 Ofo) 
1 (100 %) 
0 (0 Ufo) 
0 (0 Ufo) 
21 (34 Ufo) 
Follow-up 
Present survivors 
(months) 
43,56,63,75,82,100 
42,51 
86 
72 
11 other patients died late after 1292, 13, 131/2, 14, 17, 20, 26, 28, 30, 41 and 72 months. 
Table 5: Liver transplantation 
August, 1976, through December, 1977 
(Follow-up to May 1, 1978) 
Total cases 30 
Alive 15* 
Dead 15 
" ::::: 6 months = 14 
:::::1year=9 
Table 6: Adult/pediatric division of 30 cases 
August, 1976, through December, 1977 
(Follow-up to May 1, 1978) 
-------------------------
Adults 
Pedi;~tric (18 years) 
Number 
of examples Alive 
18 
12 
8 (44 Ufo) 
7 (58 %) 
Follow-up 
6-20 months 
4-20 months 
" -
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Fig. 1: Serum biochemistries during the 11 years and 81/2 months of survival of a.mongrel dog 
following orthotopic liver transplantation from a mongrel recipient on March 23, 1964. The 
values recorded during the last 8 months of life represent individual determinations. All other 
points on the graph are mean values for each time period; the brackets indicate 1 SD above and 
below the mean. Beginning with the 7th year of follow-up, bilirubin concentrations, if normal, 
were reported as < 1.2 mgOfo. The upper limit of normal in our laboratory for each test is 
marked by the horizontal broken line. (By permission of Transplantation 23 [1977] 168-171) 
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Fig. 2: Course of the patient before and after liver replacement. AG: agarose gel immunodiffu-
sion test for HBsAg. (By permission of Arch. Surg., in press, 1978) 
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Fig. 3: The course of a patient with Wilson's disease who received an orthotopic liver homograft 
more than 7 years ago. Note that the cerulo-plasmin rose from undetectable to normal levels 
and that there was a heightened urinary copper excretion for almost a year. In this patient 
cyclophosphamide and azathioprine were used interchangeably. The deterioration in liver 
function starting just after a month was caused by serum hepatitis (HBsAg). (By permission of 
Transplantation Proc. 5 (1) [1973] 829-833) 
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Fig. 4: Technique of retrograde removal of 
liver. A, Incisions. AA, Subcostal incision 
used for all orthotopic liver transplantations. 
BB, CC and DD, Frequently used extensions 
from the AA incision. B, Beginning retro-
grade removal after transection of inferior 
vena cava and hilar structures. All posterior 
tissue that is cut should be ligated, although 
the named vessels encountered, such as the 
right adrenal vein, are few in number. (By 
permission of Surg. Gynecol. Obstet. 142 
h •• a"" [1976] 487-505) 
Fig. 5: A, Operative field after retrograde 
liver mobilization. The last remaining 
structure, the suprahepatic inferior vena 
cava, has been clamped above the liver. 
B, Technique for mobilizing a suitable 
length of suprahepatic vena cava after 
placement of clamp. In adults, this usu-
ally involves cutting away cirrhotic liver 
tissue over the frequently distorted and 
foreshortened right and left hepatic veins. 
(By permission of Surg. Gynecol. Obstet. 
142 [1976] 487-505) 
Fig. 6: Techniques of biliary duct recon-
struction used for most of the transplanta-
tion recipients. A, Cholecystoduodenosto-
my. B, Cholecystojejunostomy. C, Chole-
dochojejunostomy after removal of gall-
bladder. D, Choledochocholedochostomy. 
Note that the T-tube is placed, if possible, 
in recipient common duct. (By permission 
of Surg. Gynecol. Obstet. 142 [1976] 487-
505) 
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Fig. 7: Technique to prevent air 
embolism from orthotopic liver 
homografts. A, Continuous per-
fusion of solution through por-
tal vein as vena caval anasto-
moses are constructed. B, C, 
Escape of air bubbles as the 
an;lstomoSes arc completed. (By 
permission of Ann. Surg. 187 
[1978]236-240) 
Fi g. 8: Tr:lnshcpatic chobngiogr:lms in four patients whose origin:ll biliary reconstructions were 
with R Oll . -cn-Y cholccystoje junostomy, as depicted in Fig. 6 B. A, minim;ll obstruction. B, Mo-
derate obstruction. C, Severe ubstruction with leak and :lbseess formation (A) ncar si te or com-
mon duct lig:l tion. D, Very severe obstruction. At reopcration the common duct was necrotic . 
(C) = cystic duct; (GB) = gallbladder; (J) = jejunum; brge arrow = site of common duct 
ligation. (By permission of Surgery 81 [1977] 222-227) 
